Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Undiagnosed Diseases Network, |
RCV000625991 | SCV000746596 | uncertain significance | Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability | 2017-03-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001756030 | SCV001987772 | uncertain significance | not provided | 2020-01-22 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Genome |
RCV002264964 | SCV002547299 | not provided | Megalencephalic leukoencephalopathy with subcortical cysts | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 04-26-2016 by lab or GTR ID 26957. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator John Constantino MD PhD from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. | |
Undiagnosed Diseases Network, |
RCV000625991 | SCV004812046 | uncertain significance | Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability | 2018-03-16 | no assertion criteria provided | clinical testing |